CRISPR-Cas technology: balancing efficiency and safety

When researchers work with CRISPR-Cas9 technologies, they have to weigh up safety against greater efficiency of the method. (Image, AI-generated: Josef Kuster / ETH Zurich) Wenn Forschende mit Crispr-Cas9-Technologien arbeiten, müssen sie zwischen Sicherheit und mehr Effizienz der Methode abwägen. (Bild, KI-generiert: Josef Kuster / ETH Zürich)

ETH News Article / Artikel
ETH Zurich researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.

Click here to read the full ETH News Article
Click here to read the publication in Nature Biotechnology (Open Access)
Website Corn Lab

Crispr-Cas: die Balance finden zwischen Effizienz und Sicherheit
ETH-Forschende decken eine gravierende Nebenwirkung bei einer Anwendung der Genschere Crispr-Cas auf. Ein Molekül, das den Vorgang effizienter machen soll, zerstört Bereiche des Genoms.

Hier klicken um den ganzen ETH News Artikel zu lesen

Back

Events

10.03.2025 16:30 - 17:30

Recent Publications

Mechanistic determinants and dynamics of cA6 synthesis in type III CRISPR-Cas effector complexes
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories
MCTS2 and distinct eIF2D roles in uORF-dependent translation regulation revealed by in vitro re-initiation assays
mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcription
DNA end sensing and cleavage by the Shedu anti-phage defense system

Click here for more information

Recent Preprints

Double-stranded RNA responses, neoantigen presentation and suppression of hepatocellular carcinoma through NMD inhibition via endonuclease SMG6
Cell heterogeneity and fate bistability drive tissue patterning during intestinal regeneration
Enhancer lncRNA LOC730338 limits the innate immune response against lymphoma cells, inhibiting ADAR2-dependent alternative transcription
In vivo single-cell ribosome profiling reveals cell-type-specific translational programs during aging
Antimicrobial activity of iron-depriving pyoverdines against human opportunistic pathogens

Click here for more information

CRISPR-Cas technology: balancing efficiency and safety

Wojciech Galej – NCCR Seminar Series (BE)

Wojciech Galej - NCCR Seminar Series (ZH)

Pietro Fratta – NCCR Seminar Series (BE)